Nuclera recognized as one of UK’s most exciting growth stage companies.
Early type 2 diabetes risk skyrockets with low birthweight and overweight at age 20
New research being presented at this year’s European Congress on Obesity (ECO) in Venice, Italy (12-15 May), and published in Diabetologia (the journal of th